When was Martindale Pharma founded?

Martindale Pharma was founded in 1787.

Where is Martindale Pharma located?

Martindale Pharma is headquartered in Wooburn Green, United Kingdom.

How many employees does Martindale Pharma have?

As of Mar 01, 2026, the latest employee count at Martindale Pharma is 200 - 499.

Where does Martindale Pharma rank among its competitors?

Martindale Pharma ranks 47th amongst 89 active competitors, of which 5 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Exela Pharma, which secured $28.3M in Sep, 2025.

Who are the top competitors of Martindale Pharma?

Martindale Pharma's top competitors include Gufic Group, Sagent Pharma and JAMP Pharma. Among them, Exela Pharma secured the most recent funding round in September, 2025.

Martindale Pharma - 2026 Company Profile, Funding & Competitors

Company Details

Manufacturer of membrane-based humidifiers for fuel cell systems. These humidifiers are passive devices, utilizing polymeric membranes to transport water vapor, enhancing fuel cell performance and durability. Products are designed for various system sizes, from low-power applications to automotive and mobile uses. The company also applies its membrane technology to energy recovery ventilators for building applications. The humidifiers are a critical component in numerous fuel cell systems globally.

Website: martindalepharma.co.uk
Social
Email ID: *****@martindalepharma.co.uk

Key Metrics

Founded Year

1787

Location

Wooburn Green, United Kingdom

Stage

Acquired

Investors

Constant Equity

Ranked

47^th among 89 active competitors

Employee Count

200 - 499 as on Mar 01, 2026

Investment & Acquisitions

Viridian Pharma

Similar Companies

Gufic Group & 98 more

Exit Details

Acquired by Ethypharm (Jan 19, 2017)

View Martindale Pharma's full profile

Martindale Pharma got acquired by Ethypharm on Jan 19, 2017.

Click here to take a look at Martindale Pharma's acquisition in detail

Martindale Pharma is a funded company. Martindale Pharma has 1 institutional investor.

View details of Martindale Pharma's funding rounds and investors

Martindale Pharma's employee count trend

Martindale Pharma has 200 - 499 employees as of Mar 26. Here is Martindale Pharma's employee count trend over the years:

Employee count trend for Martindale Pharma

Uncover Martindale Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Martindale Pharma include Gufic Group, Sagent Pharma and JAMP Pharma. Here is the list of Top 10 competitors of Martindale Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Gufic Group 1970, Mumbai (India), Public	Manufacturer of lyophilized injections and pharmaceutical products	-	-	52/100
2nd	Sagent Pharma 2006, Schaumburg (United States), Acquired	Provider of injectable generic pharmaceuticals	$153M	Zhejiang Hisun Pharmaceuticals, MidCap Financial ... & 3 others	51/100
3rd	JAMP Pharma 1988, Boucherville (Canada), Late Stage	Manufacturer of injectables	-	Fonds de solidarite FTQ	51/100
4th	ImprimisRx 1998, Roxbury Township (United States), Seed	Developer of proprietary sterile and topical drug formulations	$80K	-	50/100
5th	Kelun Pharmaceutical 1996, Chengdu (China), Public	Manufacturer of pharmaceutical products and related services	-	Yonghua Capital	49/100
6th	Innopharma 2005, Piscataway (United States), Acquired	Manufacturer of injectable pharmaceutical products	$23M	Thomas, McNerney & Partners, Comerica & 1 others	49/100
7th	Nanolek 2011, Moscow (Russia), Late Stage	Manufacturer of biopharmaceuticals and vaccines	$43.7M	Sberbank, Rusnano	48/100
8th	Otsuka Pharmaceutical India 2012, Ahmedabad (India), Unfunded	Manufacturer of intravenous infusions and clinical nutrition products	-	-	48/100
9th	Exela Pharma 2005, Lenoir (United States), Series B	Manufacturer of sterile injectable pharmaceutical products and CDMO services	$6.67M	Trinity Capital, Baruch Future Ventures & 3 others	46/100
10th	Amphastar Pharmaceuticals 1996, Rancho Cucamonga (United States), Public	Manufacturer of injectable and inhalation products	-	YFY, Yet2ventures & 2 others	46/100
47th	Martindale Pharma 1787, Wooburn Green (United Kingdom), Acquired	Manufacturer of membrane-based humidifiers for fuel cell systems	-	Constant Equity	28/100